Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate nasal spray vs cetirizine in seasonal allergic rhinitis
NCT01916226Phase 4Completed
- Sponsor
- GSK
- Start
- Aug 2013
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by GSK. Started Aug 2013; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01916226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916226.